CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer’s disease

References

Atagi, Y., Liu, C.-C., Painter, M.M., Chen, X.-F., Verbeeck, C., Zheng, H., Li, X., Rademakers, R., Kang, S.S., Xu, H., et al. (2015). Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J. Alzheimers. Dis. 290, 26043–26050.10.1074/jbc.M115.679043Search in Google Scholar PubMed PubMed Central

Azizi, G., Khannazer, N., and Mirshafiey, A. (2014). The potential role of chemokines in Alzheimer’s disease pathogenesis. Am. J. Alzheimers. Dis. 29, 415–425.10.1177/1533317513518651Search in Google Scholar PubMed

Balschun, D., Randolf, A., Pitossi, F., Schneider, H., Rey, A., and Besedovsky, H.O. (2003). Hippocampal interleukin-1β gene expression during long-term potentiation decays with age. Ann. N.Y. Acad. Sci. 992, 1–8.10.1111/j.1749-6632.2003.tb03132.xSearch in Google Scholar PubMed

Barclay, A.N. (1981). Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX 2 antigens. Immunology 44, 727–736.Search in Google Scholar

Bazan, J.F., Bacon, K.B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D.R., Zlotnik, A., and Schall, T.J. (1997). A new class of membrane-bound chemokine with a CX(3)C motif. Nature 385, 640–644.10.1038/385640a0Search in Google Scholar PubMed

Beattie, E.C., Stellwagen, D., Morishita, W., Bresnahan, J.C., Ha, B.K., Von Zastrow, M., Beattie, M.S., and Malenka, R.C. (2002). Control of synaptic strength by glial TNFα. Science 295, 2282–2285.10.1126/science.1067859Search in Google Scholar PubMed

Bemiller, S.M., McCray, T.J., Allan, K., Formica, S.V., Xu, G., Wilson, G., Kokiko-Cochran, O.N., Crish, S.D., Lasagna-Reeves, C.A., Ransohoff, R.M., et al. (2017). TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol. Neurodegener. 12, 74.10.1186/s13024-017-0216-6Search in Google Scholar PubMed PubMed Central

Boehme, S.A., Lio, F.M., Maciejewski-Lenoir, D., Bacon, K.B., and Conlon, P.J. (2000). The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J. Immunol. 165, 397–403.10.4049/jimmunol.165.1.397Search in Google Scholar PubMed

Bolós, M., Perea, J.R., and Avila, J. (2017). Alzheimer’s disease as an inflammatory disease. Biomol. Concepts 8, 37–43.10.1515/bmc-2016-0029Search in Google Scholar PubMed

Bouchon, A., Hernandez-Munain, C., Cella, M., and Colonna, M. (2001). A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194, 1111–1122.10.1084/jem.194.8.1111Search in Google Scholar PubMed PubMed Central

Butovsky, O., Jedrychowski, M.P., Moore, C.S., Cialic, R., Lanser, A.J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P.M., Doykan, C.E., et al. (2014). Identification of a unique TGF-β dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131–143.10.1038/nn.3599Search in Google Scholar PubMed PubMed Central

Cardona, A.E., Pioro, E.P., Sasse, M.E., Kostenko, V., Cardona, S.M., Dijkstra, I.M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006). Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917–924.10.1038/nn1715Search in Google Scholar PubMed

Chen, P., Zhao, W., Guo, Y., Xu, J., and Yin, M. (2016). CX3CL1/CX3CR1 in Alzheimer’s disease: a target for neuroprotection. BioMed. Res. Int. 2016, 8090918.10.1155/2016/8090918Search in Google Scholar PubMed PubMed Central

Costello, D.A., Lyons, A., Denieffe, S., Browne, T.C., Cox, F.F., and Lynch, M.A. (2011). Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: a role for Toll-like receptor activation. J. Biol. Chem. 286, 34722–34732.10.1074/jbc.M111.280826Search in Google Scholar PubMed PubMed Central

Cox, F.F., Carney, D., Miller, A.-M., and Lynch, M.A. (2012). CD200 fusion protein decreases microglial activation in the hippocampus of aged rats. Brain Behav. Immun. 26, 789–796.10.1016/j.bbi.2011.10.004Search in Google Scholar PubMed

Daws, M.R., Sullam, P.M., Niemi, E.C., Chen, T.T., Tchao, N.K., and Seaman, W.E. (2003). Pattern recognition by TREM-2: binding of anionic ligands. J. Immunol. 171, 594–599.10.4049/jimmunol.171.2.594Search in Google Scholar PubMed

Deisseroth, K. (2014). Circuit dynamics of adaptive and maladaptive behaviour. Nature 505, 309–317.10.1038/nature12982Search in Google Scholar PubMed PubMed Central

Delpech, J.C., Madore, C., Nadjar, A., Joffre, C., Wohleb, E.S., and Layé, S. (2015). Microglia in neuronal plasticity: influence of stress. Neuropharmacology 96, 19–28.10.1016/j.neuropharm.2014.12.034Search in Google Scholar PubMed

Desforges, N.M., Hebron, M.L., Algarzae, N.K., Lonskaya, I., and Moussa, C.E.H. (2012). Fractalkine mediates communication between pathogenic proteins and microglia: implications of anti-inflammatory treatments in different stages of neurodegenerative diseases. Int. J. Alzheimers. Dis. 2012, 345472.10.1155/2012/345472Search in Google Scholar PubMed PubMed Central

Dissing-Olesen, L., LeDue, J.M., Rungta, R.L., Hefendehl, J.K., Choi, H.B., and MacVicar, B.A. (2014). Activation of neuronal NMDA receptors triggers transient ATP-mediated microglial process outgrowth. J. Neurosci. 34, 10511–10527.10.1523/JNEUROSCI.0405-14.2014Search in Google Scholar PubMed PubMed Central

Duan, R.-S., Yang, X., Chen, Z.-G., Lu, M.-O., Morris, C., Winblad, B., and Zhu, J. (2008). Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice. Neurochem. Res. 33, 1085–1089.10.1007/s11064-007-9554-zSearch in Google Scholar PubMed

Fontainhas, A.M., Wang, M., Liang, K.J., Chen, S., Mettu, P., Damani, M., Fariss, R.N., Li, W., and Wong, W.T. (2011). Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission. PLoS One 6, e15973.10.1371/journal.pone.0015973Search in Google Scholar PubMed PubMed Central

Frank, S., Burbach, G.J., Bonin, M., Walter, M., Streit, W., Bechmann, I., and Deller, T. (2008). TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 56, 1438–1447.10.1002/glia.20710Search in Google Scholar PubMed

Frautschy, S.A., Yang, F.S., Irrizarry, M., Hyman, B., Saido, T.C., Hsiao, K., and Cole, G.M. (1998). Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152, 307–317.Search in Google Scholar

Fuhrmann, M., Bittner, T., Jung, C.K.E., Burgold, S., Page, R.M., Mitteregger, G., Haass, C., LaFerla, F.M., Kretzschmar, H., and Herms, J. (2010). Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer’s disease. Nat. Neurosci. 13, 411–413.10.1038/nn.2511Search in Google Scholar PubMed PubMed Central

Garton, K.J., Gough, P.J., Blobel, C.P., Murphy, G., Greaves, D.R., Dempsey, P.J., and Raines, E.W. (2001). Tumor necrosis factor-α-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 276, 37993–38001.10.1074/jbc.M106434200Search in Google Scholar PubMed

Gosselin, D., Link, V.M., Romanoski, C.E., Fonseca, G.J., Eichenfield, D.Z., Spann, N.J., Stender, J.D., Chun, H.B., Garner, H., Geissmann, F., et al. (2014). Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159, 1327–1340.10.1016/j.cell.2014.11.023Search in Google Scholar PubMed PubMed Central

Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J.S.K., Lupton, M.K., et al. (2013). TREM2 variants in Alzheimer’s disease. N. Engl. J. Med. 368, 117–127.10.1056/NEJMoa1211851Search in Google Scholar PubMed PubMed Central

Hanzel, C.E., Pichet-Binette, A., Pimentel, L.S.B., Iulita, M.F., Allard, S., Ducatenzeiler, A., Do Carmo, S., and Cuello, A.C. (2014). Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer’s disease. Neurobiol Aging 35, 2249–2262.10.1016/j.neurobiolaging.2014.03.026Search in Google Scholar PubMed

Hariri, A.R. and Holmes, A. (2015). Finding translation in stress research. Nat. Neurosci. 18, 1347–1352.10.1038/nn.4111Search in Google Scholar PubMed PubMed Central

Harrison, J.K., Jiang, Y., Chen, S.Z., Xia, Y.Y., Maciejewski, D., McNamara, R.K., Streit, W.J., Salafranca, M.N., Adhikari, S., Thompson, D.A., et al. (1998). Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA 95, 10896–10901.10.1073/pnas.95.18.10896Search in Google Scholar PubMed PubMed Central

Hatherley, D. and Barclay, A.N. (2004). The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur. J. Immunol. 34, 1688–1694.10.1002/eji.200425080Search in Google Scholar PubMed

Heneka, M.T., Carson, M.J., El Khoury, J., Landreth, G.E., Brosseron, F., Feinstein, D.L., Jacobs, A.H., Wyss-Coray, T., Vitorica, J., Ransohoff, R.M., et al. (2015). Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 14, 388–405.10.1016/S1474-4422(15)70016-5Search in Google Scholar

Hensley, K. (2010). Neuroinflammation in Alzheimer’s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J. Alzheimers. Dis. 21, 1–14.10.3233/JAD-2010-1414Search in Google Scholar PubMed PubMed Central

Hernangomez, M., Carrillo-Salinas, F.J., Mecha, M., Correa, F., Mestre, L., Loria, F., Feliu, A., Docagne, F., and Guaza, C. (2014). Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system. Curr. Pharm. Des. 20, 4707–4722.10.2174/1381612820666140130202911Search in Google Scholar PubMed PubMed Central

Hickman, S.E. and El Khoury, J. (2014). TREM2 and the neuroimmunology of Alzheimer’s disease. Biochem. Pharmacol. 88, 495–498.10.1016/j.bcp.2013.11.021Search in Google Scholar PubMed PubMed Central

Hsieh, C.L., Koike, M., Spusta, S.C., Niemi, E.C., Yenari, M., Nakamura, M.C., and Seaman, W.E. (2009). A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J. Neurochem. 109, 1144–1156.10.1111/j.1471-4159.2009.06042.xSearch in Google Scholar PubMed PubMed Central

Ito, H. and Hamerman, J.A. (2012). TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur. J. Immunol. 42, 176–185.10.1002/eji.201141679Search in Google Scholar PubMed PubMed Central

Jiang, T., Yu, J.-T., Zhu, X.-C., and Tan, L. (2013). TREM2 in Alzheimer’s disease. Mol. Neurobiol. 48, 180–185.10.1007/s12035-013-8424-8Search in Google Scholar PubMed

Jiang, T., Tan, L., Zhu, X.-C., Zhang, Q.-Q., Cao, L., Tan, M.-S., Gus, L.-Z., Wang, H.-F., Ding, Z.-Z., Zhang, Y.-D., et al. (2014). Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer’s disease. Neuropsychopharmacology 39, 2949–2962.10.1038/npp.2014.164Search in Google Scholar PubMed PubMed Central

Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P.V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A.I., Lah, J.J., et al. (2013). Variant of TREM2 associated with the risk of Alzheimer’s disease. N. Engl. J. Med. 368, 107–116.10.1056/NEJMoa1211103Search in Google Scholar PubMed PubMed Central

Jung, S., Aliberti, J., Graemmel, P., Sunshine, M.J., Kreutzberg, G.W., Sher, A., and Littman, D.R. (2000). Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20, 4106–4114.10.1128/MCB.20.11.4106-4114.2000Search in Google Scholar PubMed PubMed Central

Jurgens, H.A. and Johnson, R.W. (2012). Dysregulated neuronal-microglial cross-talk during aging, stress and inflammation. Exp. Neurol. 233, 40–48.10.1016/j.expneurol.2010.11.014Search in Google Scholar PubMed PubMed Central

Kawabori, M., Kacimi, R., Kauppinen, T., Calosing, C., Kim, J.Y., Hsieh, C.L., Nakamura, M.C., and Yenari, M.A. (2015). Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J. Neurosci. 35, 3384–3396.10.1523/JNEUROSCI.2620-14.2015Search in Google Scholar PubMed PubMed Central

Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T.K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017). A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290.10.1016/j.cell.2017.05.018Search in Google Scholar PubMed

Kettenmann, H., Kirchhoff, F., and Verkhratsky, A. (2013). Microglia: new roles for the synaptic stripper. Neuron 77, 10–18.10.1016/j.neuron.2012.12.023Search in Google Scholar PubMed

Kierdorf, K. and Prinz, M. (2013). Factors regulating microglia activation. Front. Cell Neurosci. 7, 44.10.3389/fncel.2013.00044Search in Google Scholar PubMed PubMed Central

Kim, T.-S., Lim, H.-K., Lee, J.Y., Kim, D.-J., Park, S., Lee, C., and Lee, C.-U. (2008). Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer’s disease. Neurosci. Lett. 436, 196–200.10.1016/j.neulet.2008.03.019Search in Google Scholar PubMed

Kiyota, T., Okuyama, S., Swan, R.J., Jacobsen, M.T., Gendelman, H.E., and Ikezu, T. (2010). CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer’s disease-like pathogenesis in APP+PS1 bigenic mice. FASEB J. 24, 3093–3102.10.1096/fj.10-155317Search in Google Scholar PubMed PubMed Central

Kober, D.L. and Brett, T.J. (2017). TREM2-ligand interactions in health and disease. J. Mol. Biol. 429, 1607–1629.10.1016/j.jmb.2017.04.004Search in Google Scholar PubMed PubMed Central

Koning, N., van Eijk, M., Pouwels, W., Brouwer, M.S.M., Voehringer, D., Huitinga, I., Hoek, R.M., Raes, G., and Hamann, J. (2010). Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation. J. Innate Immun. 2, 195–200.10.1159/000252803Search in Google Scholar PubMed

Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017). The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566–581.e569.10.1016/j.immuni.2017.08.008Search in Google Scholar PubMed PubMed Central

Landel, V., Baranger, K., Virard, I., Loriod, B., Khrestchatisky, M., Rivera, S., Benech, P., and Feron, F. (2014). Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease. Mol. Neurodegener. 9, 33.10.1186/1750-1326-9-33Search in Google Scholar PubMed PubMed Central

Lee, C.Y.D. and Landreth, G.E. (2010). The role of microglia in amyloid clearance from the AD brain. J. Neural Transm. 117, 949–960.10.1007/s00702-010-0433-4Search in Google Scholar PubMed PubMed Central

Lee, S., Varvel, N.H., Konerth, M.E., Xu, G., Cardona, A.E., Ransohoff, R.M., and Lamb, B.T. (2010). CX3CR1 deficiency alters microglial activation and reduces β-amyloid deposition in two Alzheimer’s disease mouse models. Am. J. Pathol. 177, 2549–2562.10.2353/ajpath.2010.100265Search in Google Scholar PubMed PubMed Central

Lee, L.C., Goh, M.Q., and Koo, E.H. (2017). Transcriptional regulation of APP by apoE: to boldly go where no isoform has gone before. Bioessays 39, 1700062.10.1002/bies.201700062Search in Google Scholar PubMed PubMed Central

Lerner, T.N., Ye, L., and Deisseroth, K. (2016). Communication in neural circuits: tools, opportunities, and challenges. Cell 164, 1136–1150.10.1016/j.cell.2016.02.027Search in Google Scholar PubMed PubMed Central

Li, X., Montine, K.S., Keene, C.D., and Montine, T.J. (2015). Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E-2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia. FASEB J. 29, 1754–1762.10.1096/fj.14-262683Search in Google Scholar PubMed PubMed Central

Lian, H. and Zheng, H. (2016). Signaling pathways regulation neuron-glia interaction and their implication in Alzheimer’s disease. J. Neurochem. 136, 475–491.10.1111/jnc.13424Search in Google Scholar PubMed PubMed Central

Lim, S.H., Park, E., You, B., Jung, Y., Park, A.R., Park, S.G., and Lee, J.R. (2013). Neuronal synapse formation induced by microglia and interleukin 10. PLoS One 8, e81218.10.1371/journal.pone.0081218Search in Google Scholar PubMed PubMed Central

Lyons, A., Downer, E.J., Crotty, S., Nolan, Y.M., Mills, K.H.G., and Lynch, M.A. (2007). CD200 ligand-receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J. Neurosci. 27, 8309–8313.10.1523/JNEUROSCI.1781-07.2007Search in Google Scholar PubMed PubMed Central

Lyons, A., McQuillan, K., Deighan, B.F., O’Reilly, J.-A., Downer, E.J., Murphy, A.C., Watson, M., Piazza, A., O’Connell, F., Griffin, R., et al. (2009). Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide. Brain Behav. Immun. 23, 1020–1027.10.1016/j.bbi.2009.05.060Search in Google Scholar PubMed

Lyons, A., Downer, E.J., Costello, D.A., Murphy, N., and Lynch, M.A. (2012). Dok2 mediates the CD200Fc attenuation of A β-induced changes in glia. J. Neuroinflamm. 9, 107.10.1186/1742-2094-9-107Search in Google Scholar

Lyons, A., Minogue, A.M., Jones, R.S., Fitzpatrick, O., Noonan, J., Campbell, V.A., and Lynch, M.A. (2016). Analysis of the impact of CD200 on phagocytosis. Mol. Neurobiol. 54, 5730–5739.10.1007/s12035-016-0223-6Search in Google Scholar

McMaster, W.R. and Williams, A.F. (1979). Identification of Ia glycoproteins in rat thymus and purification from rat spleen. Eur. J. Immunol. 9, 426–433.10.1002/eji.1830090603Search in Google Scholar

Melchior, B., Garcia, A.E., Hsiung, B.-K., Lo, K.M., Doose, J.M., Thrash, J.C., Stalder, A.K., Staufenbiel, M., Neumann, H., and Carson, M.J. (2010). Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer’s disease. Asn Neuro. 2, 157–170.10.1042/AN20100010Search in Google Scholar

Mihrshahi, R., Barclay, A.N., and Brown, M.H. (2009). Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J. Immunol. 183, 4879–4886.10.4049/jimmunol.0901531Search in Google Scholar

Mizuno, T., Kawanokuchi, J., Numata, K., and Suzumura, A. (2003). Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 979, 65–70.10.1016/S0006-8993(03)02867-1Search in Google Scholar

Moynagh, P.N. (2005). The interleukin-1 signalling pathway in astrocytes: a key contributor to inflammation in the brain. J. Anat. 207, 265–269.10.1111/j.1469-7580.2005.00445.xSearch in Google Scholar PubMed PubMed Central

Murphy, K.J. (2013). Neuron-glia crosstalk in health and disease: fractalkine and CX(3)CR1 take centre stage. Open Biol. 3, 130181.10.1098/rsob.130181Search in Google Scholar PubMed PubMed Central

N’Diaye, E.-N., Branda, C.S., Branda, S.S., Nevarez, L., Colonna, M., Lowell, C., Hamerman, J.A., and Seaman, W.E. (2009). TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J. Cell. Biol. 184, 215–223.10.1083/jcb.200808080Search in Google Scholar PubMed PubMed Central

Neumann, H. and Daly, M.J. (2013). Variant TREM2 as risk factor for Alzheimer’s disease. N. Engl. J. Med. 368, 182–184.10.1056/NEJMe1213157Search in Google Scholar PubMed

Nimmervoll, B., White, R., Yang, J.W., An, S., Henn, C., Sun, J.J., and Luhmann, H.J. (2012). LPS-induced microglial secretion of TNFα increases activity-dependent neuronal apoptosis in the neonatal cerebral cortex. Cereb. Cortex 23, 1742–1755.10.1093/cercor/bhs156Search in Google Scholar

Noda, M., Doi, Y., Liang, J., Kawanokuchi, J., Sonobe, Y., Takeuchi, H., Mizuno, T., and Suzumura, A. (2011). Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J. Biol. Chem. 286, 2308–2319.10.1074/jbc.M110.169839Search in Google Scholar

Painter, M.M., Atagi, Y., Liu, C.-C., Rademakers, R., Xu, H., Fryer, J.D., and Bu, G. (2015). TREM2 in CNS homeostasis and neurodegenerative disease. Mol. Neurodegener. 10, 43.10.1186/s13024-015-0040-9Search in Google Scholar

Paolicelli, R.C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T.A., Guiducci, E., Dumas, L., et al. (2011). Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456–1458.10.1126/science.1202529Search in Google Scholar

Perlmutter, L.S., Barron, E., and Chui, H.C. (1990). Morphologic association between microglia and senile plaque amyloid in Alzheimer’s disease. Neurosci. Lett. 119, 32–36.10.1016/0304-3940(90)90748-XSearch in Google Scholar

Pocock, J.M. and Kettenmann, H. (2007). Neurotransmitter receptors on microglia. Trends Neurosci. 30, 527–535.10.1016/j.tins.2007.07.007Search in Google Scholar PubMed

Podbielska, M., Das, A., Smith, A.W., Chauhan, A., Ray, S.K., Inoue, J., Azuma, M., Nozaki, K., Hogan, E.L., and Banik, N.L. (2016). Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation. J. Neurochem. 139, 440–455.10.1111/jnc.13774Search in Google Scholar PubMed PubMed Central

Poliani, P.L., Wang, Y., Fontana, E., Robinette, M.L., Yamanish, Y., Gilfillan, S., and Colonna, M. (2015). TREM2 sustains microglial expansion during aging and response to demyelination. J. Clin. Invest. 125, 2161–2170.10.1172/JCI77983Search in Google Scholar PubMed PubMed Central

Ransohoff, R.M. (2016). How neuroinflammation contributes to neurodegeneration. Science 353, 777–783.10.1126/science.aag2590Search in Google Scholar PubMed

Rogers, J.T., Morganti, J.M., Bachstetter, A.D., Hudson, C.E., Peters, M.M., Grimmig, B.A., Weeber, E.J., Bickford, P.C., and Gemma, C. (2011). CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J. Neurosci. 31, 16241–16250.10.1523/JNEUROSCI.3667-11.2011Search in Google Scholar PubMed PubMed Central

Salminen, A., Ojala, J., Kauppinen, A., Kaarniranta, K., and Suuronen, T. (2009). Inflammation in Alzheimer’s disease: amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors. Prog. Neurobiol. 87, 181–194.10.1016/j.pneurobio.2009.01.001Search in Google Scholar PubMed

Stancu, I.-C., Vasconcelos, B., Terwel, D., and Dewachter, I. (2014). Models of β-amyloid induced Tau-pathology: the long and ‘folded’ road to understand the mechanism. Mol. Neurodegen. 9, 51.10.1186/1750-1326-9-51Search in Google Scholar PubMed PubMed Central

Strobel, S., Gruenblatt, E., Riederer, P., Heinsen, H., Arzberger, T., Al-Sarraj, S., Troakes, C., Ferrer, I., and Monoranu, C.M. (2015). Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer’s disease progression: CX3CL1, TREM2, and PPARγ. J. Neural Transm. 122, 1069–1076.10.1007/s00702-015-1369-5Search in Google Scholar PubMed

Takahashi, K., Rochford, C.D.P., and Neumann, H. (2005). Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201, 647–657.10.1084/jem.20041611Search in Google Scholar PubMed PubMed Central

Tan, M.-S., Yu, J.-T., Jiang, T., Zhu, X.-C., Wang, H.-F., Zhang, W., Wang, Y.-L., Jiang, W., and Tan, L. (2013). NLRP3 polymorphisms are associated with late-onset Alzheimer’s disease in Han Chinese. J. Neuroimmunol. 265, 91–95.10.1016/j.jneuroim.2013.10.002Search in Google Scholar PubMed

Tang, Y. and Le, W. (2016). Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol. Neurobiol. 53, 1181–1194.10.1007/s12035-014-9070-5Search in Google Scholar PubMed

Turnbull, I.R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., and Colonna, M. (2006). Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177, 3520–3524.10.4049/jimmunol.177.6.3520Search in Google Scholar PubMed

Varnum, M.M. and Ikezu, T. (2012). The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer’s disease brain. Arch. Immunol. Ther. Ex. 60, 251–266.10.1007/s00005-012-0181-2Search in Google Scholar PubMed PubMed Central

Varnum, M.M., Kiyota, T., Ingraham, K.L., Ikezu, S., and Ikezu, T. (2015). The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer’s disease. Neurobiol Aging 36, 2995–3007.10.1016/j.neurobiolaging.2015.07.027Search in Google Scholar PubMed PubMed Central

Walker, D.G. and Lue, L.-F. (2013). Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains? Future Neurol. 8, 321–332.10.2217/fnl.13.14Search in Google Scholar PubMed PubMed Central

Walker, D.G., Dalsing-Hernandez, J.E., Campbell, N.A., and Lue, L.-F. (2009). Decreased expression of CD200 and CD200 receptor in Alzheimer’s disease: a potential mechanism leading to chronic inflammation. Exp. Neurol. 215, 5–19.10.1016/j.expneurol.2008.09.003Search in Google Scholar PubMed PubMed Central

Walter, S., Letiembre, M., Liu, Y., Heine, H., Penke, B., Hao, W., Bode, B., Manietta, N., Walter, J., Schulz-Schaeffer, W., et al. (2007). Role of the toll-like receptor 4 in neuro-inflammation in Alzheimer’s disease. Cell. Physiol. Biochem. 20, 947–956.10.1159/000110455Search in Google Scholar PubMed

Wang, Y., Cella, M., Mallinson, K., Ulrich, J.D., Young, K.L., Robinette, M.L., Gilfillan, S., Krishnan, G.M., Sudhakar, S., Zinselmeyer, B.H., et al. (2015). TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model. Cell 160, 1061–1071.10.1016/j.cell.2015.01.049Search in Google Scholar PubMed PubMed Central

Webb, M. and Barclay, A.N. (1984). Localisation of the MRC OX-2 glycoprotein on the surfaces of neurones. J. Neurochem. 43, 1061–1067.10.1111/j.1471-4159.1984.tb12844.xSearch in Google Scholar PubMed

Wohleb, E.S. (2016). Neuron-microglia interactions in mental health disorders: ‘for better, and for worse’. Front Immunol. 7, 544.10.3389/fimmu.2016.00544Search in Google Scholar PubMed PubMed Central

Wolf, S.A., Boddeke, H.W.G.M., and Kettenmann, H. (2017). Microglia in physiology and disease. Annu. Rev. Physiol. 79, 619–643.10.1146/annurev-physiol-022516-034406Search in Google Scholar PubMed

Xiang, X., Werner, G., Bohrmann, B., Liesz, A., Mazaheri, F., Capell, A., Feederle, R., Knuesel, I., Kleinberger, G., and Haass, C. (2016). TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance. EMBO Mol. Med. 8, 992–1004.10.15252/emmm.201606370Search in Google Scholar PubMed PubMed Central

Yamamoto, M., Kiyota, T., Walsh, S.M., Liu, J., Kipnis, J., and Ikezu, T. (2008). Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes. J. Immunol. 181, 3877–3886.10.4049/jimmunol.181.6.3877Search in Google Scholar PubMed PubMed Central

Yeo, S.I., Kim, J.E., Ryu, H.J., Seo, C.H., Lee, B.C., Choi, I.G., Kim, D.S., and Kang, T.C. (2011). The roles of fractalkine/CX3CR1 system in neuronal death following pilocarpine-induced status epilepticus. J. Neuroimmunol. 234, 93–102.10.1016/j.jneuroim.2011.03.005Search in Google Scholar PubMed

Zhao, W., Dumanis, S.B., Tamboli, I.Y., Rodriguez, G.A., Jo LaDu, M., Moussa, C.E., and William Rebeck, G. (2013). Human APOE genotype affects intraneuronal Aβ1-42 accumulation in a lentiviral gene transfer model. Human Mol Genet 23, 1365–1375.10.1093/hmg/ddt525Search in Google Scholar PubMed PubMed Central

Zheng, H., Liu, C.-C., Atagi, Y., Chen, X.-F., Jia, L., Yang, L., He, W., Zhang, X., Kang, S.S., Rosenberry, T.L., et al. (2016). Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Neurobiol Aging 42, 132–141.10.1016/j.neurobiolaging.2016.03.004Search in Google Scholar

Zhong, L., Chen, X.-F., Zhang, Z.-L., Wang, Z., Shi, X.-Z., Xu, K., Zhang, Y.-W., Xu, H., and Bu, G. (2015). DAP12 stabilizes the C-terminal fragment of the triggering receptor expressed on myeloid cells-2 (TREM2) and protects against LPS-induced pro-inflammatory response. J. Biol. Chem. 290, 15866–15877.10.1074/jbc.M115.645986Search in Google Scholar

Zujovic, V., Benavides, J., Vige, X., Carter, C., and Taupin, V. (2000). Fractalkine modulates TNF-α secretion and neurotoxicity induced by microglial activation. Glia 29, 305–315.10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-VSearch in Google Scholar